This topic contains a solution. Click here to go to the answer

Author Question: A client with co-occurring disorders of schizophrenia and substance abuse is admitted for treatment. ... (Read 50 times)

fox

  • Hero Member
  • *****
  • Posts: 540
A client with co-occurring disorders of schizophrenia and substance abuse is admitted for treatment. Which of the following would the nurse be least likely to identify as a priority for this client?
 
  A) Assessment
  B) Group therapy
  C) Control of psychiatric symptoms
  D) Treatment of withdrawal symptoms

Question 2

The nurse is assessing a client who has borderline personality disorder. Which of the following would be a priority?
 
  A) Nutrition patterns
  B) Personal hygiene practices
  C) Physical functioning
  D) Somatic complaints



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

livaneabi

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

B

Answer to Question 2

C




fox

  • Member
  • Posts: 540
Reply 2 on: Jul 19, 2018
Excellent


AmberC1996

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library